{"news_desk": "SundayBusiness", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By GRETCHEN MORGENSON", "person": [{"rank": 1, "role": "reported", "firstname": "Gretchen", "organization": "", "lastname": "MORGENSON"}]}, "abstract": "Gretchen Morgenson Fair Game column questions why Wall Street analysts continue to support Valeant Pharmaceuticals International; notes company misstated earnings and tried to keep investors in dark about SEC investigation. ", "type_of_material": "News", "word_count": "999", "lead_paragraph": "A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals\u2019 financial disclosures, despite attempts to burnish results.", "pub_date": "2016-03-06T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "A Troubling Timeline at Valeant", "content_kicker": "Fair Game", "print_headline": "A Troubling Blooper Reel at Valeant", "kicker": "Fair Game"}, "snippet": "A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals\u2019 financial disclosures, despite attempts to burnish results.", "multimedia": [{"height": 126, "url": "images/2016/03/06/business/06gret1/06gret1-thumbWide-v3.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/06/business/06gret1/06gret1-thumbWide-v3.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 527, "url": "images/2016/03/06/business/06gret1/06gret1-articleLarge-v3.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "527", "xlarge": "images/2016/03/06/business/06gret1/06gret1-articleLarge-v3.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/06/business/06gret1/06gret1-thumbStandard-v3.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/06/business/06gret1/06gret1-thumbStandard-v3.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/06/business/a-troubling-timeline-at-valeant.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Company Reports", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "56d9cd9c38f0d83eee09783c", "source": "The New York Times"}